Thursday, December 31, 2009

Benoral




Benoral may be available in the countries listed below.


Ingredient matches for Benoral



Phenoxymethylpenicillin

Phenoxymethylpenicillin benzathine (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Benoral in the following countries:


  • Spain

International Drug Name Search

Sunday, December 27, 2009

Vosol HC


Vosol HC is a brand name of acetic acid/hydrocortisone otic, approved by the FDA in the following formulation(s):


VOSOL HC (acetic acid, glacial; hydrocortisone - solution/drops; otic)



  • Manufacturer: HI TECH PHARMA

    Approved Prior to Jan 1, 1982

    Strength(s): 2%;1% [RLD][AT]

Has a generic version of Vosol HC been approved?


Yes. The following products are equivalent to Vosol HC:


ACETASOL HC (acetic acid, glacial; hydrocortisone solution/drops; otic)



  • Manufacturer: ACTAVIS MID ATLANTIC

    Approval date: January 13, 1982

    Strength(s): 2%;1% [AT]

HYDROCORTISONE AND ACETIC ACID (acetic acid, glacial; hydrocortisone solution/drops; otic)



  • Manufacturer: TARO

    Approval date: March 4, 1985

    Strength(s): 2%;1% [AT]


  • Manufacturer: VINTAGE

    Approval date: February 6, 2006

    Strength(s): 2%;1% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vosol HC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Vosol HC.

See also...

  • Vosol HC Advanced Consumer Information (Micromedex)
  • Acetic Acid/Hydrocortisone Solution Consumer Information (Wolters Kluwer)
  • Acetic acid and hydrocortisone otic Consumer Information (Cerner Multum)
  • Hydrocortisone and acetic acid Otic Advanced Consumer Information (Micromedex)

Friday, December 25, 2009

Razadyne ER Extended-Release Capsules


Pronunciation: gal-AN-ta-meen
Generic Name: Galantamine
Brand Name: Razadyne ER


Razadyne ER Extended-Release Capsules are used for:

Treating mild to moderate dementia (eg, impairment of memory or judgement, abstract thinking, changes in personality) in patients with Alzheimer disease.


Razadyne ER Extended-Release Capsules are a cholinesterase inhibitor. It works by increasing the amount of a certain substance (acetylcholine) in the brain, which may help reduce symptoms of dementia in patients with Alzheimer disease.


Do NOT use Razadyne ER Extended-Release Capsules if:


  • you are allergic to any ingredient in Razadyne ER Extended-Release Capsules

  • you have severely decreased liver or kidney function

Contact your doctor or health care provider right away if any of these apply to you.



Before using Razadyne ER Extended-Release Capsules:


Some medical conditions may interact with Razadyne ER Extended-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of liver or kidney problems, certain heart problems (eg, slow or irregular heartbeat, sick sinus syndrome), stomach or bowel problems (eg, ulcer, blockage), lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD]), or urinary blockage

  • if you have brain lesions or tumors, increased pressure in the brain, recent head injury, or a history of seizures (eg, epilepsy)

  • if you have dementia or other decreased mental ability that is not caused by Alzheimer disease

Some MEDICINES MAY INTERACT with Razadyne ER Extended-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen) because the risk of stomach or bowel bleeding may be increased

  • Cholinergic agents (eg, bethanechol), cholinesterase inhibitors (eg, donepezil), ketoconazole, or serotonin specific reuptake inhibitors (eg, paroxetine) because they may increase the risk of Razadyne ER Extended-Release Capsules's side effects

  • Anticholinergics (eg, scopolamine) because their effectiveness may be decreased by Razadyne ER Extended-Release Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Razadyne ER Extended-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Razadyne ER Extended-Release Capsules:


Use Razadyne ER Extended-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Razadyne ER Extended-Release Capsules by mouth in the morning, unless your doctor tells you otherwise. You may take it with or without food, but taking it with food is recommended.

  • Swallow Razadyne ER Extended-Release Capsules whole. Do not break, crush, or chew before swallowing.

  • Drinking extra fluids while you are taking Razadyne ER Extended-Release Capsules are recommended. Check with your doctor for instructions.

  • Take Razadyne ER Extended-Release Capsules on a regular schedule to get the most benefit from it.

  • Taking Razadyne ER Extended-Release Capsules at the same time each day will help you remember to take it.

  • Continue to take Razadyne ER Extended-Release Capsules even if you feel well. Do not miss any doses.

  • If you miss a dose of Razadyne ER Extended-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. Contact your doctor if you miss several doses of Razadyne ER Extended-Release Capsules. Your doctor may need to restart your medicine at a lower dose to avoid side effects.

Ask your health care provider any questions you may have about how to use Razadyne ER Extended-Release Capsules.



Important safety information:


  • Razadyne ER Extended-Release Capsules may cause dizziness, drowsiness, or fainting. These effects may be worse if you take it with alcohol or certain medicines. Use Razadyne ER Extended-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not take more than the recommended dose without checking with your doctor.

  • When you begin taking Razadyne ER Extended-Release Capsules, your doctor will increase your dose slowly over several months. This may help to decrease the risk of certain side effects (eg, nausea, vomiting, diarrhea). Carefully follow the dosing schedule prescribed by your doctor.

  • Tell your doctor or dentist that you take Razadyne ER Extended-Release Capsules before you receive any medical or dental care, emergency care, or surgery.

  • Razadyne ER Extended-Release Capsules should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Razadyne ER Extended-Release Capsules while you are pregnant. It is not known if Razadyne ER Extended-Release Capsules are found in breast milk. Razadyne ER Extended-Release Capsules are not approved for use in women who may be breast-feeding.


Possible side effects of Razadyne ER Extended-Release Capsules:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; dizziness; headache; loss of appetite; nausea; stomach upset; tiredness; vomiting; weight loss.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody, black, or tarry stools; chest pain; decreased urination; depression; fainting; fever; seizures; severe or persistent tiredness or weakness; slow or irregular heartbeat; tremor.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Razadyne ER side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; increased sweating or saliva production; loss of bowel control; loss of consciousness; muscle weakness; seizures; severe dizziness; severe nausea or vomiting; slow heartbeat; slow or shallow breathing; stomach cramping.


Proper storage of Razadyne ER Extended-Release Capsules:

Store Razadyne ER Extended-Release Capsules at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Razadyne ER Extended-Release Capsules out of the reach of children and away from pets.


General information:


  • If you have any questions about Razadyne ER Extended-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.

  • Razadyne ER Extended-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Razadyne ER Extended-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Razadyne ER resources


  • Razadyne ER Side Effects (in more detail)
  • Razadyne ER Use in Pregnancy & Breastfeeding
  • Drug Images
  • Razadyne ER Drug Interactions
  • Razadyne ER Support Group
  • 2 Reviews for Razadyne ER - Add your own review/rating


Compare Razadyne ER with other medications


  • Alzheimer's Disease

Wednesday, December 23, 2009

Co Vals




Co Vals may be available in the countries listed below.


Ingredient matches for Co Vals



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co Vals in the following countries:


  • Spain

Valsartan

Valsartan is reported as an ingredient of Co Vals in the following countries:


  • Spain

International Drug Name Search

Heparin Calcium




Heparin Calcium may be available in the countries listed below.


UK matches:

  • Heparin calcium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion (SPC)

Ingredient matches for Heparin Calcium



Heparin

Heparin Calcium (BANM, JAN) is known as Heparin in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, December 21, 2009

Rhogam


Generic Name: rho(d) immune globulin (Injection route, Intramuscular route, Intravenous route)


roe-dee i-MUNE GLOB-ue-lin


Intravenous route(Powder for Solution;Solution)

Intravascular hemolysis (IVH) leading to death has been reported in patients treated for immune thrombocytopenic purpura (ITP) with Rho(D) immune globulin. IVH can lead to clinically compromising anemia and multi-system organ failure, including acute respiratory distress syndrome (ARDS), acute renal insufficiency, renal failure, and disseminated intravascular coagulation (DIC). Alert patients and closely monitor for the signs and symptoms of IVH in a health care setting for at least eight hours after administration for ITP. Perform a dipstick urinalysis at baseline, 2 hours, 4 hours after administration, and prior to the end of the monitoring period. If signs and/or symptoms of IVH are present or suspected, post-treatment laboratory tests should be performed, including plasma hemoglobin, haptoglobin, LDH, and plasma bilirubin (direct and indirect) .



Commonly used brand name(s)

In the U.S.


  • BayRho-D

  • HyperRHO S/D

  • MicRhogam Ultra-Filtered

  • Rhogam

  • RhoGAM Ultra-Filtered Plus

  • Rhophylac

  • WinRho SDF

In Canada


  • Winrho SDF

Available Dosage Forms:


  • Powder for Solution

  • Solution

  • Injectable

Therapeutic Class: Immune Serum


Uses For Rhogam


Rho(D) immune globulin is used to treat immune thrombocytopenic purpura (ITP) in patients with Rh-positive blood. ITP is a type of blood disorder where the person has a very low number of platelets. Platelets help to clot the blood. Rho(D) immune globulin is also used to prevent antibodies from forming after a person with Rh-negative blood receives a transfusion with Rh-positive blood, or during pregnancy when a mother has Rh-negative blood and the baby is Rh-positive. It belongs to a group of medicines called immunizing agents. Rho(D) immune globulin works to boost the immune system and prevent excessive bleeding.


The Rh factor is one part of the red blood cell. A person has either Rh-positive or Rh-negative blood. If you receive the opposite type of blood, your body will create antibodies that can destroy the red blood cells. When a pregnant woman is Rh-negative and her baby is Rh-positive, the baby's blood can get into her system and cause her to make antibodies. When the same woman has a second baby with Rh-positive blood, the antibodies will destroy the red blood cells in the baby. Rho(D) immune globulin is given to these women during pregnancy or after delivery to prevent them from making antibodies.


This medicine is to be administered only by or under the supervision of your doctor.


Before Using Rhogam


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Rho(D) immune globulin in children. It is not recommended for an infant with Rh-positive blood whose mother is Rh-negative.


Geriatric


Although appropriate studies on the relationship of age to the effects of Rho(D) immune globulin have not been performed in the geriatric population, geriatric-specific problems are not expected to limit the usefulness of Rho(D) immune globulin in the elderly. However, elderly patients are more likely to have age-related heart, kidney, or liver problems, and might have conditions that require an adjustment in the dose for patients receiving Rho(D) immune globulin.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Varicella Virus Vaccine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Anemia, severe or

  • Blood clotting problems, history of or

  • Breathing problems, severe or

  • Disseminated intravascular coagulation (blood clotting problem) or

  • Kidney problems or

  • Pulmonary edema (fluid in the lungs), history of—Use with caution. May make these conditions worse.

  • Atherosclerosis (hardening of the arteries), history of or

  • Heart or blood vessel problems or

  • Hyperviscosity (thick blood), history of or

  • Stroke—Use with caution. May cause side effects to become worse.

  • Autoimmune hemolytic anemia (bleeding problem) or

  • Hemolysis, active (red blood cells are being destroyed) or

  • Immunoglobulin A (IgA) deficiency with antibodies against IgA—Should not be used in patients with these conditions.

  • Diabetes—The liquid form of WinRho® contains maltose. Some glucose testing systems will not work properly if maltose is in the blood. Discuss this with your doctor.

Proper Use of rho(d) immune globulin

This section provides information on the proper use of a number of products that contain rho(d) immune globulin. It may not be specific to Rhogam. Please read with care.


A nurse or other trained health professional will give you this medicine in a hospital. This medicine is given through a needle placed in one of your veins or as a shot into one of your muscles.


Precautions While Using Rhogam


It is very important that your doctor check the progress of you or your child at regular visits for any problems or unwanted effects that may be caused by this medicine. Blood and urine tests may be needed to check for unwanted effects.


Check with your doctor right away if you or your child have back pain; shaking chills; a fever; dark urine; a decreased amount of urine; a sudden weight gain; swelling of the hands or feet; or shortness of breath after receiving this medicine. These may be symptoms of a serious blood problem called intravascular hemolysis (IVH).


This medicine is made from donated human blood. Some human blood products have transmitted certain viruses to people who have received them. The risk of getting a virus from medicines made from human blood has been greatly reduced in recent years. This is the result of required testing of human donors for certain viruses, and testing during the making of these medicines. Although the risk is low, talk with your doctor if you have concerns.


This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor right away if you or your child have itching, a rash, hives, chest pain, dizziness or lightheadedness, trouble breathing, or any swelling of your hands, face, or mouth after you receive this medicine.


This medicine may cause blood clots, especially in patients with a history of blood clotting problems, heart disease, and atherosclerosis (hardening of the arteries) or circulation problems. Patients who stay in bed for a long time because of surgery or illness may also have blood clots. Check with your doctor right away if you or your child suddenly have chest pain, shortness of breath, a severe headache, leg pain, or problems with vision, speech, or walking.


This medicine may cause a rare and serious lung problem a few hours after it is given. Tell your doctor right away if you or your child have any breathing problems with or without a fever after you receive the medicine.


While you are being treated with Rho(D) immune globulin, do not have any immunizations (vaccines) without your doctor's approval. Live virus vaccines should not be given for 3 months after receiving Rho(D) immune globulin.


Rhogam Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


Rare
  • Bloody urine

  • decreased frequency of urination or amount of urine

  • fever

  • increased blood pressure

  • increased thirst

  • loss of appetite

  • lower back pain

  • nausea or vomiting

  • pale skin

  • swelling of the face, fingers, or lower legs

  • troubled breathing

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Soreness at the place of injection

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rhogam side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Rhogam resources


  • Rhogam Side Effects (in more detail)
  • Rhogam Use in Pregnancy & Breastfeeding
  • Rhogam Drug Interactions
  • Rhogam Support Group
  • 0 Reviews for Rhogam - Add your own review/rating


  • Bayrho-D full dose

  • HyperRHO S/D Full Dose Prescribing Information (FDA)

  • RhoGAM MedFacts Consumer Leaflet (Wolters Kluwer)

  • RhoGAM Ultra-Filtered PLUS Prescribing Information (FDA)

  • Rhophylac Consumer Overview

  • Rhophylac MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rhophylac Prescribing Information (FDA)

  • WinRho SDF MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Rhogam with other medications


  • Idiopathic Thrombocytopenic Purpura
  • Rh-Isoimmunization

Friday, December 18, 2009

Gamofa D




Gamofa D may be available in the countries listed below.


Ingredient matches for Gamofa D



Famotidine

Famotidine is reported as an ingredient of Gamofa D in the following countries:


  • Japan

International Drug Name Search

Thursday, December 17, 2009

Farmacaina Pomada




Farmacaina Pomada may be available in the countries listed below.


Ingredient matches for Farmacaina Pomada



Lidocaine

Lidocaine is reported as an ingredient of Farmacaina Pomada in the following countries:


  • Colombia

International Drug Name Search

Flunarizina La Santé




Flunarizina La Santé may be available in the countries listed below.


Ingredient matches for Flunarizina La Santé



Flunarizine

Flunarizine is reported as an ingredient of Flunarizina La Santé in the following countries:


  • Colombia

International Drug Name Search

Sunday, December 13, 2009

Clast




Clast may be available in the countries listed below.


Ingredient matches for Clast



Clebopride

Clebopride malate (a derivative of Clebopride) is reported as an ingredient of Clast in the following countries:


  • Indonesia

  • Japan

International Drug Name Search

Tuesday, December 8, 2009

Piracemed




Piracemed may be available in the countries listed below.


Ingredient matches for Piracemed



Piracetam

Piracetam is reported as an ingredient of Piracemed in the following countries:


  • Belgium

International Drug Name Search

Sunday, December 6, 2009

Klarmyn




Klarmyn may be available in the countries listed below.


Ingredient matches for Klarmyn



Clarithromycin

Clarithromycin is reported as an ingredient of Klarmyn in the following countries:


  • Mexico

  • Philippines

International Drug Name Search

Saturday, December 5, 2009

Ketlac




Ketlac may be available in the countries listed below.


Ingredient matches for Ketlac



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Ketlac in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, December 2, 2009

Kinin SAD




Kinin SAD may be available in the countries listed below.


Ingredient matches for Kinin SAD



Quinine

Quinine hydrochloride (a derivative of Quinine) is reported as an ingredient of Kinin SAD in the following countries:


  • Denmark

International Drug Name Search

Thursday, November 26, 2009

Penzital




Penzital may be available in the countries listed below.


Ingredient matches for Penzital



Pancreatin

Pancreatin is reported as an ingredient of Penzital in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday, November 25, 2009

Casicot




Casicot may be available in the countries listed below.


Ingredient matches for Casicot



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Casicot in the following countries:


  • South Africa

Trimethoprim

Trimethoprim is reported as an ingredient of Casicot in the following countries:


  • South Africa

International Drug Name Search

Kalnonon




Kalnonon may be available in the countries listed below.


Ingredient matches for Kalnonon



Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Kalnonon in the following countries:


  • Japan

International Drug Name Search

Perfane




Perfane may be available in the countries listed below.


Ingredient matches for Perfane



Enoximone

Enoximone is reported as an ingredient of Perfane in the following countries:


  • Luxembourg

International Drug Name Search

Monday, November 16, 2009

Paluxon




Paluxon may be available in the countries listed below.


Ingredient matches for Paluxon



Paroxetine

Paroxetine is reported as an ingredient of Paluxon in the following countries:


  • Croatia (Hrvatska)

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paluxon in the following countries:


  • Slovenia

International Drug Name Search

Sunday, November 15, 2009

Basazyde




Basazyde may be available in the countries listed below.


Ingredient matches for Basazyde



Balsalazide

Balsalazide disodium salt, dihydrate (a derivative of Balsalazide) is reported as an ingredient of Basazyde in the following countries:


  • Taiwan

International Drug Name Search

Friday, November 13, 2009

KadeFungin Milchsäurekur




KadeFungin Milchsäurekur may be available in the countries listed below.


Ingredient matches for KadeFungin Milchsäurekur



Lactic Acid

Lactic Acid is reported as an ingredient of KadeFungin Milchsäurekur in the following countries:


  • Germany

Lactic Acid sodium (a derivative of Lactic Acid) is reported as an ingredient of KadeFungin Milchsäurekur in the following countries:


  • Germany

International Drug Name Search

K.C.L




K.C.L may be available in the countries listed below.


Ingredient matches for K.C.L



Potassium Chloride

Potassium Chloride is reported as an ingredient of K.C.L in the following countries:


  • Japan

International Drug Name Search

Thursday, November 12, 2009

Curon




Curon may be available in the countries listed below.


Ingredient matches for Curon



Vecuronium

Vecuronium Bromide is reported as an ingredient of Curon in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, November 8, 2009

Sykes




Sykes may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sykes



Levamisole

Levamisole is reported as an ingredient of Sykes in the following countries:


  • Australia

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Sykes in the following countries:


  • Australia

International Drug Name Search

Friday, November 6, 2009

Natovit




Natovit may be available in the countries listed below.


Ingredient matches for Natovit



Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Natovit in the following countries:


  • Italy

International Drug Name Search

Thursday, November 5, 2009

Chloral Hydrate




In the US, Chloral Hydrate (chloral hydrate systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Insomnia and Sedation.

US matches:

  • Chloral Hydrate

  • Chloral Hydrate Suppositories

  • Chloral Hydrate Syrup

  • Chloral hydrate rectal

  • Chloral hydrate Oral, Rectal

Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

N05CC01

CAS registry number (Chemical Abstracts Service)

0000302-17-0

Chemical Formula

C2-H3-Cl3-O2

Molecular Weight

165

Therapeutic Categories

Agent for premedication

Hypnotic and sedative agent

Chemical Name

1,1-Ethanediol, 2,2,2-trichloro-

Foreign Names

  • Chlorali hydras (Latin)
  • Chloralhydrat (German)
  • Chloral (hydrate de) (French)

Generic Names

  • Chloral (hydrate de) (OS: DCF)
  • Chloral Hydrate (OS: BAN)
  • Cloral Hydrate (IS)
  • Trichloroethylidene glycol (IS)
  • Chloral (hydrate de) (PH: Ph. Eur. 6)
  • Chloral Hydrate (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
  • Chloralhydrat (PH: Ph. Eur. 6)
  • Chlorali hydras (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Aquachloral
    PolyMedica, United States


  • Chloral Hydrate Odan
    Odan, Canada


  • Chloral Hydrate Syrup
    Pharmaceutical Associates, United States


  • Chloral Hydrate
    Biomed, New Zealand; Orion, Australia; Orion, New Zealand


  • Chloraldurat
    Pohl-Boskamp, Switzerland; Pohl-Boskamp, Germany


  • Escre
    Hisamitsu, Japan


  • Kloral SAD
    Amgros, Denmark


  • Nervifene
    Interdelta, Switzerland


  • PMS-Chloral Hydrate
    Pharmascience, Singapore


  • Welldorm
    Alphashow, United Kingdom; Alphashow, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, November 4, 2009

Trapiloid




Trapiloid may be available in the countries listed below.


Ingredient matches for Trapiloid



Trapidil

Trapidil is reported as an ingredient of Trapiloid in the following countries:


  • Japan

International Drug Name Search

Sunday, November 1, 2009

BS-ratiopharm




BS-ratiopharm may be available in the countries listed below.


Ingredient matches for BS-ratiopharm



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of BS-ratiopharm in the following countries:


  • Germany

International Drug Name Search

Wednesday, October 28, 2009

Merbromina Sella




Merbromina Sella may be available in the countries listed below.


Ingredient matches for Merbromina Sella



Merbromin

Merbromin is reported as an ingredient of Merbromina Sella in the following countries:


  • Italy

International Drug Name Search

Monday, October 26, 2009

DDAVP


Generic Name: desmopressin (oral) (DEZ mo press in)

Brand Names: DDAVP


What is desmopressin?

Desmopressin is a man-made form of a hormone that occurs naturally in the pituitary gland. This hormone is important for many functions including blood flow, blood pressure, kidney function, and regulating how the body uses water.


Desmopressin is used to treat bed-wetting, central cranial diabetes insipidus, and increased thirst and urination caused by head surgery or head trauma.


Desmopressin may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about oral desmopressin?


It is very important to reduce your intake of water and other fluids while you are taking desmopressin. Drinking too much water can cause your body to lose sodium, which may lead to a serious, life-threatening electrolyte imbalance.

Fluid restriction is especially important in children and older adults taking desmopressin. Follow your doctor's instructions about the type and amount of liquids you should drink.


You should not use this medication if you have severe kidney disease or if you have ever had hyponatremia (low sodium levels in your body).

Before taking desmopressin, tell your doctor if you have heart disease, coronary artery disease, congestive heart failure, kidney disease, cystic fibrosis, high or low blood pressure, an electrolyte imbalance, or a psychological disorder that causes extreme or unusual thirst.


To be sure desmopressin is helping your condition, your blood will need to be tested often. This will help your doctor determine how long to treat you with this medication. Do not miss any scheduled appointments.


What should I discuss with my healthcare provider before taking oral desmopressin?


You should not take this medication if you are allergic to desmopressin, or if you have:

  • severe kidney disease; or




  • if you have ever had hyponatremia (low sodium levels in your body).



Before taking desmopressin, tell your doctor if you are allergic to any medications, or if you have:



  • heart disease, coronary artery disease;




  • congestive heart failure;




  • kidney disease;




  • cystic fibrosis;




  • high or low blood pressure;




  • an electrolyte imbalance; or




  • a psychologic disorder that causes extreme or unusual thirst.



If you have any of these conditions, you may need a dose adjustment or special tests to safely take desmopressin.


FDA pregnancy category B. This medication is not expected to harm an unborn baby. Do not use desmopressin without telling your doctor if you are pregnant. It is not known whether desmopressin passes into breast milk, or if it could harm a nursing baby. Do not use desmopressin without telling your doctor if you are breast-feeding a baby.

How should I take desmopressin?


Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


It is very important to reduce your intake of water and other fluids while you are taking desmopressin. Drinking too much water can cause your body to lose sodium, which may lead to a serious, life-threatening electrolyte imbalance.

Fluid restriction is especially important in children and older adults taking desmopressin. Follow your doctor's instructions about the type and amount of liquids you should drink.


If you are switching from desmopressin nasal spray to desmopressin tablets, wait at least 24 hours after your last nasal dose before you take your first tablet.

To be sure this medication is helping your condition, your blood will need to be tested often. This will help your doctor determine how long to treat you with desmopressin. Do not miss any scheduled appointments.


Store the tablets at room temperature away from moisture, light, and heat.

See also: DDAVP dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include headache, confusion, drowsiness, rapid weight gain, or urination problems.


What should I avoid while taking desmopressin?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are taking desmopressin.


Desmopressin side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop taking desmopressin and call your doctor at once if you have any of these serious side effects:

  • nausea, vomiting, weakness, loss of appetite, headache, feeling restless or irritable, confusion, hallucinations, muscle pain or weakness, and/or seizure;




  • feeling like you might pass out;




  • swelling, weight gain; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).



Less serious side effects may include:



  • headache;




  • nausea, mild stomach pain;




  • diarrhea; or




  • warmth, redness, or tingly feeling in your face.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect desmopressin?


Many drugs can interact with desmopressin. Below is just a partial list. Tell your doctor if you are using:



  • carbamazepine (Carbatrol, Tegretol);




  • chlorpromazine (Thorazine);




  • lamotrigine (Lamictal);




  • oxybutynin (Ditropan, Urotrol, Oxytrol);




  • vasopressin (Pitressin);




  • a narcotic pain medicine such as fentanyl (Actiq, Duragesic), hydrocodone (Lortab, Vicodin), oxycodone (Oxycontin), and others;




  • an "SSRI" antidepressant such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), paroxetine (Paxil), or sertraline (Zoloft);




  • a tricyclic antidepressant such as amitriptyline (Elavil, Etrafon), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Sinequan), imipramine (Janimine, Tofranil), and others;




  • medicine to treat erectile dysfunction, such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra);




  • drugs to treat high blood pressure or a prostate disorder, such as alfuzosin (Uroxatral), doxazosin (Cardura), prazosin (Minipress), terazosin (Hytrin), tamsulosin (Flomax);




  • a beta-blocker such as atenolol (Tenormin), bisoprolol (Zebeta, Ziac), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), or timolol (Blocadren); or




  • an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), and others.



This list is not complete and there may be other drugs that can interact with desmopressin. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More DDAVP resources


  • DDAVP Side Effects (in more detail)
  • DDAVP Dosage
  • DDAVP Use in Pregnancy & Breastfeeding
  • Drug Images
  • DDAVP Drug Interactions
  • DDAVP Support Group
  • 6 Reviews for DDAVP - Add your own review/rating


  • DDAVP Prescribing Information (FDA)

  • DDAVP MedFacts Consumer Leaflet (Wolters Kluwer)

  • DDAVP Advanced Consumer (Micromedex) - Includes Dosage Information

  • Desmopressin Prescribing Information (FDA)

  • Desmopressin Acetate Monograph (AHFS DI)

  • Minirin Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • Stimate Prescribing Information (FDA)

  • Stimate Spray MedFacts Consumer Leaflet (Wolters Kluwer)



Compare DDAVP with other medications


  • Diabetes Insipidus
  • Hemophilia A
  • Primary Nocturnal Enuresis
  • von Willebrand's Disease


Where can I get more information?


  • Your pharmacist can provide more information about desmopressin.

See also: DDAVP side effects (in more detail)


Thursday, October 22, 2009

Ketamina Fabra




Ketamina Fabra may be available in the countries listed below.


Ingredient matches for Ketamina Fabra



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Ketamina Fabra in the following countries:


  • Argentina

International Drug Name Search

Acéfylline heptaminol




Acéfylline heptaminol may be available in the countries listed below.


Ingredient matches for Acéfylline heptaminol



Heptaminol

Acéfylline heptaminol (DCF) is also known as Heptaminol (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, October 16, 2009

Ketmax




Ketmax may be available in the countries listed below.


Ingredient matches for Ketmax



Levamisole

Levamisole is reported as an ingredient of Ketmax in the following countries:


  • Ethiopia

International Drug Name Search

Thursday, October 15, 2009

Dipronova




Dipronova may be available in the countries listed below.


Ingredient matches for Dipronova



Betamethasone

Betamethasone 17α,21-dipropionate and 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Dipronova in the following countries:


  • El Salvador

  • Guatemala

  • Honduras

  • Mexico

  • Nicaragua

International Drug Name Search

Apo-Doxy




Apo-Doxy may be available in the countries listed below.


Ingredient matches for Apo-Doxy



Doxycycline

Doxycycline is reported as an ingredient of Apo-Doxy in the following countries:


  • Peru

  • Singapore

  • Vietnam

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Apo-Doxy in the following countries:


  • Canada

International Drug Name Search

Tuesday, October 13, 2009

Omeprazol-Teva




Omeprazol-Teva may be available in the countries listed below.


Ingredient matches for Omeprazol-Teva



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol-Teva in the following countries:


  • Denmark

  • Germany

  • Slovakia

  • Spain

  • Sweden

International Drug Name Search

Cefpodoxime Teva Enfants et Nourrissons




Cefpodoxime Teva Enfants et Nourrissons may be available in the countries listed below.


Ingredient matches for Cefpodoxime Teva Enfants et Nourrissons



Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cefpodoxime Teva Enfants et Nourrissons in the following countries:


  • France

International Drug Name Search

Friday, October 9, 2009

Tallis




Tallis may be available in the countries listed below.


Ingredient matches for Tallis



Terbinafine

Terbinafine is reported as an ingredient of Tallis in the following countries:


  • Tunisia

International Drug Name Search

Panuron




Panuron may be available in the countries listed below.


Ingredient matches for Panuron



Pancuronium

Pancuronium Bromide is reported as an ingredient of Panuron in the following countries:


  • Venezuela

International Drug Name Search

Wednesday, October 7, 2009

Coolspan




Coolspan may be available in the countries listed below.


Ingredient matches for Coolspan



Sulpiride

Sulpiride is reported as an ingredient of Coolspan in the following countries:


  • Japan

International Drug Name Search

Wednesday, September 30, 2009

Bristopen




Bristopen may be available in the countries listed below.


Ingredient matches for Bristopen



Oxacillin

Oxacillin is reported as an ingredient of Bristopen in the following countries:


  • Tunisia

Oxacillin sodium (a derivative of Oxacillin) is reported as an ingredient of Bristopen in the following countries:


  • Algeria

  • Benin

  • Burkina Faso

  • Burundi

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Mauritius

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Saturday, September 19, 2009

Albendazol La Santé




Albendazol La Santé may be available in the countries listed below.


Ingredient matches for Albendazol La Santé



Albendazole

Albendazole is reported as an ingredient of Albendazol La Santé in the following countries:


  • Colombia

International Drug Name Search

Friday, September 18, 2009

Nipogalin




Nipogalin may be available in the countries listed below.


Ingredient matches for Nipogalin



Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Nipogalin in the following countries:


  • Greece

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Nipogalin in the following countries:


  • Greece

  • Malta

International Drug Name Search

Thursday, September 10, 2009

Cipla-Lamivudine




Cipla-Lamivudine may be available in the countries listed below.


Ingredient matches for Cipla-Lamivudine



Lamivudine

Lamivudine is reported as an ingredient of Cipla-Lamivudine in the following countries:


  • South Africa

International Drug Name Search

Aténolol EG




Aténolol EG may be available in the countries listed below.


Ingredient matches for Aténolol EG



Atenolol

Atenolol is reported as an ingredient of Aténolol EG in the following countries:


  • France

International Drug Name Search

Monday, September 7, 2009

Ampivet




Ampivet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ampivet



Ampicillin

Ampicillin is reported as an ingredient of Ampivet in the following countries:


  • Switzerland

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Ampivet in the following countries:


  • Austria

  • Sweden

International Drug Name Search

Friday, August 28, 2009

Fentora




In the US, Fentora (fentanyl systemic) is a member of the drug class narcotic analgesics and is used to treat Breakthrough Pain and Pain.

US matches:

  • Fentora

  • Fentora buccal

Ingredient matches for Fentora



Fentanyl

Fentanyl is reported as an ingredient of Fentora in the following countries:


  • United States

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentora in the following countries:


  • United States

International Drug Name Search

Wednesday, August 26, 2009

Zestoretic


Zestoretic is a brand name of hydrochlorothiazide/lisinopril, approved by the FDA in the following formulation(s):


ZESTORETIC (hydrochlorothiazide; lisinopril - tablet; oral)



  • Manufacturer: ASTRAZENECA

    Approval date: July 20, 1989

    Strength(s): 25MG;20MG [RLD][AB]


  • Manufacturer: ASTRAZENECA

    Approval date: September 20, 1990

    Strength(s): 12.5MG;20MG [RLD][AB]


  • Manufacturer: ASTRAZENECA

    Approval date: November 18, 1993

    Strength(s): 12.5MG;10MG [AB]

Has a generic version of Zestoretic been approved?


Yes. The following products are equivalent to Zestoretic:


LISINOPRIL AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; lisinopril tablet; oral)



  • Manufacturer: APOTEX INC

    Approval date: October 5, 2004

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: AUROBINDO

    Approval date: March 14, 2006

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: LUPIN

    Approval date: September 27, 2006

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: PRINSTON INC

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: RANBAXY

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: SANDOZ

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: July 1, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]


  • Manufacturer: WEST WARD

    Approval date: July 8, 2002

    Strength(s): 12.5MG;10MG [AB], 12.5MG;20MG [AB], 25MG;20MG [AB]

PRINZIDE (hydrochlorothiazide; lisinopril tablet; oral)



  • Manufacturer: MERCK

    Approval date: February 16, 1989

    Strength(s): 12.5MG;20MG [AB]


  • Manufacturer: MERCK

    Approval date: November 18, 1993

    Strength(s): 12.5MG;10MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zestoretic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Zestoretic.

See also...

  • Zestoretic Consumer Information (Drugs.com)
  • Zestoretic Consumer Information (Wolters Kluwer)
  • Zestoretic Consumer Information (Cerner Multum)
  • Zestoretic Advanced Consumer Information (Micromedex)
  • Lisinopril/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
  • Hydrochlorothiazide and lisinopril Consumer Information (Cerner Multum)
  • Lisinopril and hydrochlorothiazide Advanced Consumer Information (Micromedex)

Tuesday, August 25, 2009

Gabapentin-CT




Gabapentin-CT may be available in the countries listed below.


Ingredient matches for Gabapentin-CT



Gabapentin

Gabapentin is reported as an ingredient of Gabapentin-CT in the following countries:


  • Germany

International Drug Name Search

Thursday, August 20, 2009

Kivizyme




Kivizyme may be available in the countries listed below.


Ingredient matches for Kivizyme



Lysozyme

Lysozyme hydrochloride (a derivative of Lysozyme) is reported as an ingredient of Kivizyme in the following countries:


  • Vietnam

International Drug Name Search

Friday, August 14, 2009

Asmasolon




Asmasolon may be available in the countries listed below.


Ingredient matches for Asmasolon



Ephedrine

Ephedrine hydrochloride (a derivative of Ephedrine) is reported as an ingredient of Asmasolon in the following countries:


  • Indonesia

Theophylline

Theophylline is reported as an ingredient of Asmasolon in the following countries:


  • Indonesia

  • Philippines

International Drug Name Search

Friday, August 7, 2009

Klonalmox




Klonalmox may be available in the countries listed below.


Ingredient matches for Klonalmox



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Klonalmox in the following countries:


  • Argentina

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Klonalmox in the following countries:


  • Argentina

International Drug Name Search

Wednesday, August 5, 2009

Worming Granules




Worming Granules may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Worming Granules



Fenbendazole

Fenbendazole is reported as an ingredient of Worming Granules in the following countries:


  • United Kingdom

International Drug Name Search

Sunday, August 2, 2009

Caristop Semanal




Caristop Semanal may be available in the countries listed below.


Ingredient matches for Caristop Semanal



Sodium Fluoride

Sodium Fluoride is reported as an ingredient of Caristop Semanal in the following countries:


  • Chile

International Drug Name Search

Sunday, July 26, 2009

Selofen




Selofen may be available in the countries listed below.


Ingredient matches for Selofen



Zaleplon

Zaleplon is reported as an ingredient of Selofen in the following countries:


  • Poland

International Drug Name Search

Sunday, July 19, 2009

Lutrepulse




In the US, Lutrepulse is a member of the drug class gonadotropin releasing hormones and is used to treat Amenorrhea and Gonadotropin Deficiency.

Ingredient matches for Lutrepulse



Gonadorelin

Gonadorelin acetate (a derivative of Gonadorelin) is reported as an ingredient of Lutrepulse in the following countries:


  • Canada

International Drug Name Search

Wednesday, July 15, 2009

Kalium




Kalium may be available in the countries listed below.


Ingredient matches for Kalium



Potassium Chloride

Potassium Chloride is reported as an ingredient of Kalium in the following countries:


  • Poland

International Drug Name Search

Thursday, July 9, 2009

Trazoteva




Trazoteva may be available in the countries listed below.


Ingredient matches for Trazoteva



Docetaxel

Docetaxel is reported as an ingredient of Trazoteva in the following countries:


  • Argentina

International Drug Name Search

Saturday, July 4, 2009

Amosol




Amosol may be available in the countries listed below.


Ingredient matches for Amosol



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amosol in the following countries:


  • Italy

International Drug Name Search

Sunday, June 28, 2009

Procain




Procain may be available in the countries listed below.


Ingredient matches for Procain



Procaine

Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Procain in the following countries:


  • Argentina

International Drug Name Search

Tuesday, June 23, 2009

Theovent




In the US, Theovent is a member of the drug class methylxanthines and is used to treat Apnea of Prematurity, Asthma - acute and Asthma - Maintenance.

Ingredient matches for Theovent



Theophylline

Theophylline is reported as an ingredient of Theovent in the following countries:


  • Bangladesh

  • Luxembourg

  • Poland

International Drug Name Search

Dramanyl II Gotas




Dramanyl II Gotas may be available in the countries listed below.


Ingredient matches for Dramanyl II Gotas



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Dramanyl II Gotas in the following countries:


  • El Salvador

  • Honduras

  • Nicaragua

International Drug Name Search

Monday, June 22, 2009

Klax




Klax may be available in the countries listed below.


Ingredient matches for Klax



Clarithromycin

Clarithromycin is reported as an ingredient of Klax in the following countries:


  • Turkey

International Drug Name Search

Friday, June 19, 2009

Cefalon




Cefalon may be available in the countries listed below.


Ingredient matches for Cefalon



Cefaclor

Cefaclor is reported as an ingredient of Cefalon in the following countries:


  • Vietnam

International Drug Name Search

Monday, June 15, 2009

Calcibone




Calcibone may be available in the countries listed below.


Ingredient matches for Calcibone



Calcium Citrate

Calcium Citrate is reported as an ingredient of Calcibone in the following countries:


  • Peru

International Drug Name Search

Etoposide-Mayne




Etoposide-Mayne may be available in the countries listed below.


Ingredient matches for Etoposide-Mayne



Etoposide

Etoposide is reported as an ingredient of Etoposide-Mayne in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, June 13, 2009

Terbinafin-1A Pharma




Terbinafin-1A Pharma may be available in the countries listed below.


Ingredient matches for Terbinafin-1A Pharma



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafin-1A Pharma in the following countries:


  • Germany

  • Hungary

International Drug Name Search

Wednesday, June 10, 2009

GenTeal




In the US, GenTeal (ocular lubricant ophthalmic) is a member of the drug class ophthalmic lubricants and irrigations and is used to treat Eye Dryness/Redness.

US matches:

  • GenTeal

  • Genteal Mild

Ingredient matches for GenTeal



Carbomer

Carbomer is reported as an ingredient of GenTeal in the following countries:


  • Indonesia

  • Peru

Hypromellose

Hypromellose is reported as an ingredient of GenTeal in the following countries:


  • Australia

  • Canada

  • Chile

  • Colombia

  • Ecuador

  • Germany

  • Hong Kong

  • Indonesia

  • Israel

  • Mexico

  • Myanmar

  • New Zealand

  • Peru

  • Singapore

  • Sri Lanka

  • Thailand

  • Turkey

  • Venezuela

International Drug Name Search

Monday, June 8, 2009

Ketorolac Grindeks




Ketorolac Grindeks may be available in the countries listed below.


Ingredient matches for Ketorolac Grindeks



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Ketorolac Grindeks in the following countries:


  • Latvia

International Drug Name Search

Sunday, June 7, 2009

Gengigel




Gengigel may be available in the countries listed below.


Ingredient matches for Gengigel



Hyaluronic Acid

Hyaluronic Acid is reported as an ingredient of Gengigel in the following countries:


  • Argentina

  • United Kingdom

International Drug Name Search

Friday, June 5, 2009

Glenamate




Glenamate may be available in the countries listed below.


Ingredient matches for Glenamate



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Glenamate in the following countries:


  • Vietnam

International Drug Name Search

Wednesday, June 3, 2009

Ketasol




Ketasol may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ketasol



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Ketasol in the following countries:


  • Austria

International Drug Name Search

Wednesday, May 27, 2009

Klorhexol




Klorhexol may be available in the countries listed below.


Ingredient matches for Klorhexol



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Klorhexol in the following countries:


  • Finland

International Drug Name Search

Wednesday, May 20, 2009

Vincristina Pfizer




Vincristina Pfizer may be available in the countries listed below.


Ingredient matches for Vincristina Pfizer



Vincristine

Vincristine sulfate (a derivative of Vincristine) is reported as an ingredient of Vincristina Pfizer in the following countries:


  • Spain

International Drug Name Search

Tuesday, May 19, 2009

Mucorhinathiol Mucoral




Mucorhinathiol Mucoral may be available in the countries listed below.


Ingredient matches for Mucorhinathiol Mucoral



Carbocisteine

Carbocisteine is reported as an ingredient of Mucorhinathiol Mucoral in the following countries:


  • Portugal

International Drug Name Search

Sunday, May 17, 2009

Enrofloxan




Enrofloxan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Enrofloxan



Enrofloxacin

Enrofloxacin is reported as an ingredient of Enrofloxan in the following countries:


  • Poland

International Drug Name Search

Friday, May 8, 2009

Oxyspas




Oxyspas may be available in the countries listed below.


Ingredient matches for Oxyspas



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxyspas in the following countries:


  • India

International Drug Name Search

Sunday, May 3, 2009

R.I.C.-Calcio




R.I.C.-Calcio may be available in the countries listed below.


Ingredient matches for R.I.C.-Calcio



Polystyrene Sulfonic Acid

Polystyrene Sulfonic Acid calcium salt (a derivative of Polystyrene Sulfonic Acid) is reported as an ingredient of R.I.C.-Calcio in the following countries:


  • Argentina

International Drug Name Search

Friday, May 1, 2009

Osteonat




Osteonat may be available in the countries listed below.


Ingredient matches for Osteonat



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Osteonat in the following countries:


  • Greece

International Drug Name Search

Tuesday, April 28, 2009

Fluoxetina Ceninter




Fluoxetina Ceninter may be available in the countries listed below.


Ingredient matches for Fluoxetina Ceninter



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Ceninter in the following countries:


  • Spain

International Drug Name Search